Skip to main content

Washington Would Get Additional $113 million in Purdue Pharma Settlement

Washington Would Get Additional $113 million in Purdue Pharma Settlement

Washington Would Get Additional $113 million in Purdue Pharma Settlement

Introduction

The state of Washington would get an additional $113 million from Purdue Pharma and the Sackler family over the company and family's role in the opioid crisis across the nation.

Washington's Attorney General Bob Ferguson and eight other attorney generals challenged the bankruptcy plan of the Sacklers family to deal with the opioid suits against Purdue. The challenge has resulted in adding up the total settlement amount from $70 million under the original plan to $183 million. The funds would help the state to overcome and deal with the opioid crisis, which has created havoc and claimed many lives.

In November, Washington delivered oral arguments on a key issue in the U.S. district court in New York City. The hearing resulted in U.S. District Court Judge Colleen McMahon agreeing with Ferguson on rejecting the bankruptcy proposal.

The spokesperson for Washington said that the individual fight of the state against the Sacklers and Purdue has helped the state to get the additional funds to address the opioid epidemic.

Ferguson informed that he had been preparing for the trial against Purdue since the company filed for bankruptcy. He even said that the settlement is subject to the approval of the bankruptcy plan and he will continue to fight the court battle even if the proceedings do not favor.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!